Navigation Links
Arthritis Foundation bestows prestigious national research award

ATLANTA, Dec. 1, 2008 The Arthritis Foundation announces the 2008 winners of the Lee C. Howley Sr. Prize for research in arthritis. The recipients, Dr. Gerard Karsenty of the Columbia University College of Physicians and Dr. Michel Nussenzweig of Rockefeller University received the award for their continued research advancements in the cure and control of rheumatic diseases.

Dr. Karsenty is recognized for his research in the development and function of the skeletal system. A graduate of the University of Paris, Dr. Karsenty received his postdoctoral fellow in the laboratory of Dr. Benoit de Crombrugghe. Prior to Dr. Karsenty's work, little was known about the molecular basis of mammalian skeletal system development and differentiation. Now, a decade later, the field is burgeoning with a plethora of new transcription factors, coactivators, corepressors, and signaling pathways that explain the development of the osteoblast from the mesenchymal stem cell, both during embryonic development and during postnatal bone formation. Dr. Karsenty is currently the Paul. A. Marks M.D. Professor and Chairman of the Department of Genetics and Development at Columbia University College of Physicians and Surgeons in New York City.

Dr. Nussenzweig is recognized for his contributions to the fields of B cell development and dendritic cell function. These studies have been crucial in providing insights into the etiology of autoimmune diseases such as rheumatoid arthritis and have paved the way to the development of novel therapies for the treatment of these diseases. After completing a medical internship, residency, and infectious disease fellowship at the Massachusetts General Hospital, Dr. Nussenzweig joined Dr. Philip Leder in the department of genetics at Harvard Medical School for postdoctoral training. Dr. Nussenzweig currently heads the laboratory of Molecular Immunology at Rockefeller University.


Contact: Carol Galbreath
Arthritis Foundation

Page: 1

Related medicine news :

1. Arthritis Foundation Renews Comprehensive Marketing Contract with Merkle
2. New Therapy Could Transform Arthritis Treatment
3. The SCOOTER Store Donates Power Wheelchair to Former Manassas Detective Stricken With Arthritis
4. Medicaid policies vary widely for rheumatoid arthritis drugs
5. Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered
6. Arthritis Foundation Honors Comerica Bank at Commitment To A Cure Awards Gala
7. Biologics Dont Raise Cancer Risk in Rheumatoid Arthritis Patients
8. Rheumatoid Arthritis May Harm Gums
9. New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers
10. Rheumatoid Arthritis a Threat to the Heart
11. Rheumatoid Arthritis Rising Among U.S. Women
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... limb amputations in the United States. Podiatrists are well aware that psychology-based patient ... therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile ... wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are ... of North America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and medical ... the devices for sale in the United States. Clarity is a Superior Dual ... Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... Atlanta, GA (PRWEB) , ... December 01, 2015 ... ... manufacturing, supports SACC-GA and SACC-USA through membership and leadership since 2008. ... and Chair for SACC-USA . Gary has spent a significant amount of ...
(Date:12/1/2015)... Charlotte, NC (PRWEB) , ... December 01, 2015 ... ... NHS Foundation Trust on receiving the 2015 HSJ Acute Sector Innovation Award on ... of improving the patient care experience, and propose exciting enhancements to the medical ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... , 1 décembre 2015 ... exposition et conférence d,Asie portant sur ... sur l,industrie manufacturière, se tiendra à ... 20 au 22 avril 2016. ... Photo - ...
(Date:11/30/2015)... PUNE, India , December 1, 2015 ... --> adds "Endometriosis - ... that provides an overview on therapeutic pipeline ... capabilities to create effective counter strategies to ... by identifying new targets and MOAs to ...
Breaking Medicine Technology: